awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q42720284-5F598376-2CAD-4AD2-A715-746E0CFD48F3
Q42720284-5F598376-2CAD-4AD2-A715-746E0CFD48F3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42720284-5F598376-2CAD-4AD2-A715-746E0CFD48F3
Phase 2 study of the JAK kinase inhibitor ruxolitinib in patients with refractory leukemias, including postmyeloproliferative neoplasm acute myeloid leukemia.
P2860
Q42720284-5F598376-2CAD-4AD2-A715-746E0CFD48F3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42720284-5F598376-2CAD-4AD2-A715-746E0CFD48F3
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
4188eaf6dd1d8278def7171e8d27995f8892c6e4
P2860
STAT signaling in the pathogenesis and treatment of leukemias.